Macaulay VM - Search Results

1

Serial analysis of resected prostate cancer suggests up-regulation of type 1 IGF receptor with disease progression.

Turney BW, Turner GD, Brewster SF, Macaulay VM. Turney BW, et al. Among authors: macaulay vm. BJU Int. 2011 May;107(9):1488-99. doi: 10.1111/j.1464-410X.2010.09556.x. Epub 2010 Sep 14. BJU Int. 2011. PMID: 20840329

2

Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.

Hellawell GO, Turner GD, Davies DR, Poulsom R, Brewster SF, Macaulay VM. Hellawell GO, et al. Among authors: macaulay vm. Cancer Res. 2002 May 15;62(10):2942-50. Cancer Res. 2002. PMID: 12019176

3

Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor.

Hellawell GO, Ferguson DJ, Brewster SF, Macaulay VM. Hellawell GO, et al. Among authors: macaulay vm. BJU Int. 2003 Feb;91(3):271-7. doi: 10.1046/j.1464-410x.2003.04061.x. BJU Int. 2003. PMID: 12581018

4

Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment.

Bohula EA, Playford MP, Macaulay VM. Bohula EA, et al. Among authors: macaulay vm. Anticancer Drugs. 2003 Oct;14(9):669-82. doi: 10.1097/00001813-200310000-00001. Anticancer Drugs. 2003. PMID: 14551500 Review.

5

Development of molecular agents for IGF receptor targeting.

Salisbury AJ, Macaulay VM. Salisbury AJ, et al. Among authors: macaulay vm. Horm Metab Res. 2003 Nov-Dec;35(11-12):843-9. doi: 10.1055/s-2004-814158. Horm Metab Res. 2003. PMID: 14710367 Review.

6

Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer.

Rochester MA, Riedemann J, Hellawell GO, Brewster SF, Macaulay VM. Rochester MA, et al. Among authors: macaulay vm. Cancer Gene Ther. 2005 Jan;12(1):90-100. doi: 10.1038/sj.cgt.7700775. Cancer Gene Ther. 2005. PMID: 15499378

7

The IGF receptor as anticancer treatment target.

Macaulay VM. Macaulay VM. Novartis Found Symp. 2004;262:235-43; discussion 243-6, 265-8. Novartis Found Symp. 2004. PMID: 15562833 Review.

8

The EGF receptor interacts with the type 1 IGF receptor and regulates its stability.

Riedemann J, Takiguchi M, Sohail M, Macaulay VM. Riedemann J, et al. Among authors: macaulay vm. Biochem Biophys Res Commun. 2007 Apr 13;355(3):707-14. doi: 10.1016/j.bbrc.2007.02.012. Epub 2007 Feb 9. Biochem Biophys Res Commun. 2007. PMID: 17307140

9

The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma.

Yuen JS, Cockman ME, Sullivan M, Protheroe A, Turner GD, Roberts IS, Pugh CW, Werner H, Macaulay VM. Yuen JS, et al. Among authors: macaulay vm. Oncogene. 2007 Oct 4;26(45):6499-508. doi: 10.1038/sj.onc.1210474. Epub 2007 May 7. Oncogene. 2007. PMID: 17486080

10

The type 1 insulin-like growth factor receptor is over-expressed in bladder cancer.

Rochester MA, Patel N, Turney BW, Davies DR, Roberts IS, Crew J, Protheroe A, Macaulay VM. Rochester MA, et al. Among authors: macaulay vm. BJU Int. 2007 Dec;100(6):1396-401. doi: 10.1111/j.1464-410X.2007.06931.x. Epub 2007 Jul 23. BJU Int. 2007. PMID: 17645417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters